Misuse of Herbal Remedies: the Case of an Outbreak of Terminal Renal Failure in Belgium

Total Page:16

File Type:pdf, Size:1020Kb

Misuse of Herbal Remedies: the Case of an Outbreak of Terminal Renal Failure in Belgium THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 4, Number 1, 1998, pp. 9-13 Mary Ann Liebert, Inc. Misuse of Herbal Remedies: The Case of an Outbreak of Terminal Renal Failure in Belgium (Chinese Herbs Nephropathy) JEAN-LOUIS VANHERWEGHEM, M.D., Ph.D. ABSTRACT At least 100 cases of extensive interstitial fibrosis of the kidneys were observed in Belgium in women who had followed a weight-loss regimen that included the use of Chinese herbs. The possible relation between the renal disease and these Chinese herbs was investigated. It was shown that the prescribed Chinese herb called Stephania tetrandra was, in fact, inad­ vertently replaced by another Chinese herb, namely Aristolochia fangchi in the powdered ex­ tracts delivered in Belgium and in France. The development of renal disease in about 100 pa­ tients exposed to the so-called Stephania tetrandra stresses the need for more stringent control of herbal medicine. INTRODUCTION tween the renal disease and these Chinese herbs was thus investigated and established In early 1992, two women, younger than 50(But , 1993; Van Haelen et al., 1994; Schmeiser years old, presented to us with extensive in­ et al., 1996). The development of the renal dis­ terstitial fibrosis of the kidney without ease in about 100 patients exposed to the so- glomerular lesions that rapidly progressed to called Stephania tetrandra stresses the need for terminal renal failure (Vanherweghem et al., better control of herbal medicine. 1993). These women, who had no previous his­ tory of renal disease, had followed, just before the renal disease, the same weight-loss regimen DESCRIPTION OF CHINESE in the same medical clinic. This clinic special­ HERBS NEPHROPATHY ized in weight-loss regimens for more than 15 years and no renal problems had been previ­ Epidemiology ously encountered. Interestingly, this diet reg­ imen consisted of a preparation containing a The exact number of patients exposed to Chi­ mixture of acetazolamide, fenfluramine, and nese herbs in Belgium is not known exactly. As­ various animal and vegetal extracts was suming that the incriminated herbs have been changed in mid-1990 by introducing powdered distributed in Belgium from May 1990 to Oc­ extracts of Chinese herbs, nominally Stephania tober 1992 (Vanherweghem et al., 1993), that tetrandra and Magnolia officinalis (Vanher­ the yearly amount of distribution was 185 to weghem et al., 1993). The possible relation be­ 200 kg of powders for under the name of Department of Nephrology, Hopital Erasme, Universite Libre de Bruxelles, Brussels, Belgium. 9 10 VANHERWEGHEM Stepiiania tetrandra (Vanherweghem et al., 1993) in approximately one-third of the patients (Van and that the mean exposure per patient aver­ Ypersele and Vanherweghem, 1995). aged 900 mg of powder per day for 6 to 12 In most of the cases, renal failure progressed months (Depierreux et al., 1994), about 1500 to despite the fact that the Chinese herbs had been 2000 persons may be assumed to have absorbed withdrawn, plasma creatinine raising from 2.5 such an amount of so-called Stephania tetrandra mg/dL to 8.5 mg/dL for a period of time rang­ powder. About 100 patients with renal disease ing from 6 to 24 months. Interestingly, steroid were recorded, thus representing about 5% of therapy was shown to slow the progression of the exposed population. The first patient the disease (Vanherweghem et al., 1996). recorded by an a posteriori epidemiological sur­ The major pathological lesion consisted of an vey was already on dialysis in April 1991. One extensive interstitial fibrosis with atrophy and patient was recorded in August 1997, despite loss of the tubules, predominantly located in the fact that the incriminated herbs had been the superficial cortex. The glomeruli were rel­ withdrawn from the market in October 1992. atively spaced. They nevertheless showed mild All patients except one, recorded to now were collapse of the capillaries and wrinkling of the women, aged from 18 to 65 years old. Thirty basement membrane. Interlobular and afferent percent of the patients apparently had stable, arterioles showed thickening of their walls due moderate renal failure with a plasma creatinine to a swelling of the endothelial cells (Depier­ below 3.0 mg/dL, and 70% of patients were in reux et al. 1994; Cosijns et al., 1994a). Mild to preterminal or terminal renal failure, treated by moderate atypia and atypical hyperplasia of maintenance dialysis or renal grafting. the urothelium was also observed in pieces of nephrectomies (Cosijns et al., 1994a). Fibrosis could also extend to the pelvis and the ureters Clinical and pathological aspects (Cosijns et al., 1994a; Jadoul et al., 1993). Renal failure was usually not suspected and Two published cases (Cosijns et al., 1994b; was discovered in most cases by routine blood Vanherweghem et al., 1995) were also compli­ testing. Dipstick analysis for proteinuria was cated by microinvasive urothelial carcinomas. negative and urinary sediment was unremark­ able (Vanherweghem et al., 1993; Van Ypersele Relations between the renal disease and and Vanherweghem, 1995). However, micro- Chinese herhs proteinuria was an hallmark of the disease: uri­ nary excretion of five low-molecular weight The time between the introduction of Chi­ proteins (beta2-microglobulin, cystatin C, Clara nese herbs in the weight-loss regimen and the cell protein, retinal binding protein) was in­ outbreak of renal disease circumscribed the creased in all Chinese herbs nephropathy search for the culprit to the Chinese herbs (CHN) patients with renal failure in relation to (Vanherweghem et al., 1993). Further epi­ the degree of renal failure (Kabanda et al. 1995). demiological survey demonstrated that only Urinary excretion of neutral endopeptidase the so-called Stephania tetrandra was associ­ used as a marker of the proximal tubular mass ated with all cases (Depierreux et al., 1994). was markedly decreased, also in relation to the The fact that tetrandrine, the alkaloid derived degree of renal failure (Nortier et al. 1997). from Stephania tetrandra could not be identi­ Taken together, these markers indicate that fied in the capsules taken by the patients sug­ proximal tubular cells were a primary target in gested that this herb might have been replaced CHN. by another toxic vegetal (Vanherweghem et Blood pressure was initially normal in half al., 1993). Inadvertent replacement of Stepha­ of the patients (Van Ypersele and Vanher­ nia tetrandra was suspected because: (1) weghem, 1995). Anemia was present and usu­ Stephania tetrandra belongs the family of Fang- ally more severe than might be anticipated ji besides Aristolochia Fang-ji (Vanherweghem from the degree of renal failure (Van Ypersele et al., 1993). Moreover, the Chinese characters and Vanherweghem, 1995). Curiously, asymp­ and pinyin name of Stephania tetrandra (Fang tomatic aortic insufficiency was demonstrated ji) are identical to that of Aristolochia fangchi. MISUSE OF HERBAL REMEDIES 11 In China, the differentiation is made by pre­ renal tissues of control cases (Schmeiser et al., fixing the name Fang ji either with the epithet 1996). Guang for Aristolochia fangchi or Han for Stephania tetrandra. Obviously, the risk of con­ fusion is considerable in Western markets; and DISCUSSION (2) pathological aspects of CHN is very simi­ lar to that of Balkan endemic nephropathy An extensive interstitial renal fibrosis re­ (BEN) (Vanherweghem et al., 1993; Depier­ sponsible for terminal renal failure, compli­ reux et al., 1994; Cosijns et al., 1994a) the cause cated in some cases by urotheliomas may thus of which is still under controversies, but some be related to the use of Chinese herbs for suggested causes include fungal and plant weight loss. It was shown that the prescribed toxins such as ochratoxin A and aristolochic Chinese herb called Stephania tetrandra was, in acids (Stephanovic and Polenakovic, 1991). fact, inadvertantly replaced by another Chinese Ochratoxin A was not found in the capsules herb, namely Aristolochia fangchi, in the pow­ taken by the patients (Vanherweghem et al., dered extracts delivered in Belgium and 1993). A first attempt to identify aristolochic France. Aristolochia species indeed contain aris­ acids in the capsules taken by the patients tolochic acids that are nephrotoxics (De Smet, failed (Vanherweghem et al., 1993). Later, 1992; Jackson et al., 1964) and carcinogens (De the prepurification steps required by the Smet, 1992; Mengs, 1988). Recently, a rapidly complex formulation of the capsules were progressive interstitial renal fibrosis was ob­ shown to partially destroy aristolochic acids. served in Spain secondary to a chronic intake Further analyses conducted on different of a Aristolochia pistolochia infusion (Pena et al., batches of powders delivered in Belgium un­ 1996). In the cases observed in Belgium, it is der the name of Stephania tetrandra showed possible that the nephrotoxic effects of Aris­ that in fact, most of them did not contain tolochia were increased by the combination of tetrandrine but aristolochic acids (But, 1993; other drugs such as acetazolamide or fenflu­ Van Haelen et al., 1994). The aristolochic acid ramine. The puzzling association of valvular content of the so-called Stephania powder var­ heart disease in about one-third of the cases ied from undetectable to 2.9 mg/g (Van Hae­ may more likely be linked to the concomitant len et al., 1994). Investigations conducted on use of fenfluramine than to the Chinese herbs a larger scale of 46 batches of "Stephania" (Connolly et al. 1997; Vanherweghem, 1997). powders distributed in Belgium show that 30 The mistake observed in Belgium was or will of them contained aristolochic acids and not be responsible for terminal renal failure in at tetrandrine; 7 of them contained tetrandrine least 70 w^omen who simply wanted to lose and not aristolochic acids; 5 of them contained weight. This disaster emphasizes that the med­ both tetrandrine and aristolochic acids; and 4 ical professions has the responsibility to keep of them did not contain either tetrandrine or in mind that the cornerstone of medicine is the aristolochic acid (P.
Recommended publications
  • Background Document: Roc: Aristolochic Acids ; 2010
    FINAL Report on Carcinogens Background Document for Aristolochic Acids September 2, 2008 U.S. Department of Health and Human Services Public Health Services National Toxicology Program Research Triangle Park, NC 27709 This Page Intentionally Left Blank RoC Background Document for Aristolochic Acids FOREWORD 1 The Report on Carcinogens (RoC) is prepared in response to Section 301 of the Public 2 Health Service Act as amended. The RoC contains a list of identified substances (i) that 3 either are known to be human carcinogens or are reasonably be anticipated to be human 4 carcinogens and (ii) to which a significant number of persons residing in the United 5 States are exposed. The Secretary, Department of Health and Human Services (HHS), has 6 delegated responsibility for preparation of the RoC to the National Toxicology Program 7 (NTP), which prepares the report with assistance from other Federal health and 8 regulatory agencies and nongovernmental institutions. 9 Nominations for (1) listing a new substance, (2) reclassifying the listing status for a 10 substance already listed, or (3) removing a substance already listed in the RoC are 11 reviewed in a multi-step, scientific review process with multiple opportunities for public 12 comment. The scientific peer-review groups evaluate and make independent 13 recommendations for each nomination according to specific RoC listing criteria. This 14 background document was prepared to assist in the review of aristolochic acids. The 15 scientific information used to prepare Sections 3 through 5 of this document must come 16 from publicly available, peer-reviewed sources. Information in Sections 1 and 2, 17 including chemical and physical properties, analytical methods, production, use, and 18 occurrence may come from published and/or unpublished sources.
    [Show full text]
  • Tempo-Spatial Pattern of Stepharine Accumulation in Stephania Glabra Morphogenic Tissues
    International Journal of Molecular Sciences Article Tempo-Spatial Pattern of Stepharine Accumulation in Stephania Glabra Morphogenic Tissues Tatiana Y. Gorpenchenko 1,* , Valeria P. Grigorchuk 1, Dmitry V. Bulgakov 1, Galina K. Tchernoded 1 and Victor P. Bulgakov 1,2,* 1 Federal Scientific Center of the East Asia Terrestrial Biodiversity (Institute of Biology and Soil Science), Far Eastern Branch of the Russian Academy of Sciences, 159 Stoletija Str., 690022 Vladivostok, Russia; [email protected] (V.P.G.); [email protected] (D.V.B.); [email protected] (G.K.T.) 2 Far Eastern Federal University, School of Biomedicine, 8 Sukhanova Str., 690950 Vladivostok, Russia * Correspondence: [email protected] (T.Y.G.); [email protected] (V.P.B.); Tel.: +7-423-231-0193 (T.Y.G.) Received: 25 December 2018; Accepted: 6 February 2019; Published: 13 February 2019 Abstract: Alkaloids attract great attention due to their valuable therapeutic properties. Stepharine, an aporphine alkaloid of Stephania glabra plants, exhibits anti-aging, anti-hypertensive, and anti-viral effects. The distribution of aporphine alkaloids in cell cultures, as well as whole plants is unknown, which hampers the development of bioengineering strategies toward enhancing their production. The spatial distribution of stepharine in cell culture models, plantlets, and mature micropropagated plants was investigated at the cellular and organ levels. Stepharine biosynthesis was found to be highly spatially and temporally regulated during plant development. We proposed that self-intoxication is the most likely reason for the failure of the induction of alkaloid biosynthesis in cell cultures. During somatic embryo development, the toxic load of alkaloids inside the cells increased.
    [Show full text]
  • Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches
    International Journal of Molecular Sciences Review Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches Etienne Empweb Anger, Feng Yu and Ji Li * Department of Clinical Pharmacy, School of Basic Medical Sciences and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China; [email protected] (E.E.A.); [email protected] (F.Y.) * Correspondence: [email protected]; Tel.: +86-139-5188-1242 Received: 25 November 2019; Accepted: 5 February 2020; Published: 10 February 2020 Abstract: Aristolochic acid (AA) is a generic term that describes a group of structurally related compounds found in the Aristolochiaceae plants family. These plants have been used for decades to treat various diseases. However, the consumption of products derived from plants containing AA has been associated with the development of nephropathy and carcinoma, mainly the upper urothelial carcinoma (UUC). AA has been identified as the causative agent of these pathologies. Several studies on mechanisms of action of AA nephrotoxicity have been conducted, but the comprehensive mechanisms of AA-induced nephrotoxicity and carcinogenesis have not yet fully been elucidated, and therapeutic measures are therefore limited. This review aimed to summarize the molecular mechanisms underlying AA-induced nephrotoxicity with an emphasis on its enzymatic bioactivation, and to discuss some agents and their modes of action to reduce AA nephrotoxicity. By addressing these two aspects, including mechanisms of action of AA nephrotoxicity and protective approaches against the latter, and especially by covering the whole range of these protective agents, this review provides an overview on AA nephrotoxicity. It also reports new knowledge on mechanisms of AA-mediated nephrotoxicity recently published in the literature and provides suggestions for future studies.
    [Show full text]
  • Aristolochic Acids Tract Urothelial Cancer Had an Unusually High Incidence of Urinary- Bladder Urothelial Cancer
    Report on Carcinogens, Fourteenth Edition For Table of Contents, see home page: http://ntp.niehs.nih.gov/go/roc Aristolochic Acids tract urothelial cancer had an unusually high incidence of urinary- bladder urothelial cancer. CAS No.: none assigned Additional case reports and clinical investigations of urothelial Known to be human carcinogens cancer in AAN patients outside of Belgium support the conclusion that aristolochic acids are carcinogenic (NTP 2008). The clinical stud- First listed in the Twelfth Report on Carcinogens (2011) ies found significantly increased risks of transitional-cell carcinoma Carcinogenicity of the urinary bladder and upper urinary tract among Chinese renal- transplant or dialysis patients who had consumed Chinese herbs or Aristolochic acids are known to be human carcinogens based on drugs containing aristolochic acids, using non-exposed patients as sufficient evidence of carcinogenicity from studies in humans and the reference population (Li et al. 2005, 2008). supporting data on mechanisms of carcinogenesis. Evidence of car- Molecular studies suggest that exposure to aristolochic acids is cinogenicity from studies in experimental animals supports the find- also a risk factor for Balkan endemic nephropathy (BEN) and up- ings in humans. per-urinary-tract urothelial cancer associated with BEN (Grollman et al. 2007). BEN is a chronic tubulointerstitial disease of the kidney, Cancer Studies in Humans endemic to Serbia, Bosnia, Croatia, Bulgaria, and Romania, that has The evidence for carcinogenicity in humans is based on (1) findings morphology and clinical features similar to those of AAN. It has been of high rates of urothelial cancer, primarily of the upper urinary tract, suggested that exposure to aristolochic acids results from consump- among individuals with renal disease who had consumed botanical tion of wheat contaminated with seeds of Aristolochia clematitis (Ivic products containing aristolochic acids and (2) mechanistic studies 1970, Hranjec et al.
    [Show full text]
  • Nephrotoxicity and Chinese Herbal Medicine
    Nephrotoxicity and Chinese Herbal Medicine Bo Yang,1,2 Yun Xie,2,3 Maojuan Guo,4 Mitchell H. Rosner,5 Hongtao Yang,1 and Claudio Ronco2,6 Abstract Chinese herbal medicine has been practicedfor the prevention, treatment, andcure of diseases forthousands of years. Herbal medicine involves the use of natural compounds, which have relatively complex active ingredients with varying degrees of side effects. Some of these herbal medicines are known to cause nephrotoxicity, which can be overlooked by physicians and patients due to the belief that herbal medications are innocuous. Some of the 1Department of nephrotoxic components from herbs are aristolochic acids and other plant alkaloids. In addition, anthraquinones, Nephrology, First flavonoids, and glycosides from herbs also are known to cause kidney toxicity. The kidney manifestations of Teaching Hospital of nephrotoxicity associated with herbal medicine include acute kidney injury, CKD, nephrolithiasis, rhabdomyolysis, Tianjin University of Traditional Chinese Fanconi syndrome, and urothelial carcinoma. Several factors contribute to the nephrotoxicity of herbal medicines, Medicine, Tianjin, including the intrinsic toxicity of herbs, incorrect processing or storage, adulteration, contamination by heavy China; 2International metals, incorrect dosing, and interactions between herbal medicines and medications. The exact incidence of kidney Renal Research injury due to nephrotoxic herbal medicine is not known. However, clinicians should consider herbal medicine use in Institute of Vicenza and 6Department of patients with unexplained AKI or progressive CKD. In addition, exposure to herbal medicine containing aristolochic Nephrology, Dialysis acid may increase risk for future uroepithelial cancers, and patients require appropriate postexposure screening. and Transplantation, Clin J Am Soc Nephrol 13: 1605–1611, 2018.
    [Show full text]
  • Evaluation of the Toxicity Potential of Acute and Sub-Acute Exposure to the Aqueous Root Extract of Aristolochia Ringens Vahl
    Journal of Ethnopharmacology 244 (2019) 112150 Contents lists available at ScienceDirect Journal of Ethnopharmacology journal homepage: www.elsevier.com/locate/jethpharm Evaluation of the toxicity potential of acute and sub-acute exposure to the aqueous root extract of Aristolochia ringens Vahl. (Aristolochiaceae) T Flora R. Aigbea,*, Oluwatoyin M. Sofidiyab, Ayorinde B. Jamesc, Abimbola A. Sowemimob, Olanrewaju K. Akinderea, Miriam O. Aliua, Alimat A. Dosunmua, Micah C. Chijiokea, Olufunmilayo O. Adeyemia a Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Medical Sciences, University of Lagos, P.M.B. 12003, Idi-Araba, Surulere, Lagos, Nigeria b Department of Pharmacognosy, Faculty of Pharmacy, College of Medicine, University of Lagos, P.M.B. 12003, Idi-Araba, Surulere, Lagos, Nigeria c Department of Biochemistry & Nutrition, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria. ARTICLE INFO ABSTRACT Keywords: Ethnopharmacological relevance: Aristolochia ringens Vahl. (Aristolochiaceae) is used traditionally in Nigeria for Aristolochia ringens managing a number of ailments including gastrointestinal disturbances, rheumatoid arthritis, pile, insomnia, Aristolochic acid I oedema, and snake bite venom. Some studies in our laboratory have demonstrated a scientific justification for Brine shrimp some of such uses. This study aims at investigating the toxicological actions of the aqueous root extract of Rodents Aristolochia ringens (AR). Sub-acute toxicity Materials and methods: Brine shrimp lethality assay was carried out using 10, 100 and 1000 μg/ml of the extract. Oral and intraperitoneal acute toxicity tests were carried out using mice. The effect of sub-acute (30 days) repeated oral exposure to the extract at 10, 50 and 250 mg/kg in rats was also evaluated via weekly assessments of body weights and general observations as well as end of exposure haematological, biochemical and histo- logical examinations of blood and tissue samples of treated rats.
    [Show full text]
  • Chemical Constituents and Pharmacology of the Aristolochia ( 馬兜鈴 Mădōu Ling) Species
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Journal of Traditional and Complementary Medicine Vol. 2, No. 4, pp. 249-266 Copyright © 2011 Committee on Chinese Medicine and Pharmacy, Taiwan. This is an open access article under the CC BY-NC-ND license. :ŽƵƌŶĂůŽĨdƌĂĚŝƚŝŽŶĂůĂŶĚŽŵƉůĞŵĞŶƚĂƌLJDĞĚŝĐŝŶĞ Journal homepagĞŚƩƉ͗ͬͬǁǁǁ͘ũƚĐŵ͘Žƌg Chemical Constituents and Pharmacology of the Aristolochia ( 馬兜鈴 mădōu ling) species Ping-Chung Kuo1, Yue-Chiun Li1, Tian-Shung Wu2,3,4,* 1 Department of Biotechnology, National Formosa University, Yunlin 632, Taiwan, ROC 2 Department of Chemistry, National Cheng Kung University, Tainan 701, Taiwan, ROC 3 Department of Pharmacy, China Medical University, Taichung 404, Taiwan, ROC 4 Chinese Medicine Research and Development Center, China Medical University and Hospital, Taichung 404, Taiwan, ROC Abstract Aristolochia (馬兜鈴 mǎ dōu ling) is an important genus widely cultivated and had long been known for their extensive use in traditional Chinese medicine. The genus has attracted so much great interest because of their numerous biological activity reports and unique constituents, aristolochic acids (AAs). In 2004, we reviewed the metabolites of Aristolochia species which have appeared in the literature, concerning the isolation, structural elucidation, biological activity and literature references. In addition, the nephrotoxicity of aristolochic acids, biosynthetic studies, ecological adaptation, and chemotaxonomy researches were also covered in the past review. In the present manuscript, we wish to review the various physiologically active compounds of different classes reported from Aristolochia species in the period between 2004 and 2011. In regard to the chemical and biological aspects of the constituents from the Aristolochia genus, this review would address the continuous development in the phytochemistry and the therapeutic application of the Aristolochia species.
    [Show full text]
  • Aristolochic Acids in Herbal Medicine: Public Health Concerns for Consumption and Poor Regulation of Botanical Products in Nigeria and West Africa
    Vol. 13(3), pp. 55-65, 10 February, 2019 DOI: 10.5897/JMPR2018.6691 Article Number: D5B079E60013 ISSN 1996-0875 Copyright © 2019 Author(s) retain the copyright of this article Journal of Medicinal Plants Research http://www.academicjournals.org/JMPR Review Aristolochic acids in herbal medicine: Public health concerns for consumption and poor regulation of botanical products in Nigeria and West Africa Okhale S. E.1*, Egharevba H. O.1, Okpara O. J.2, Ugbabe G. E.3, Ibrahim J. A.2, Fatokum O. T.3, Sulyman A. O.2 and Igoli J. O.3 1Department of Medicinal Plant Research and Traditional Medicine, National Institute for Pharmaceutical Research and Development, P. M. B. 21, Garki, Abuja, Nigeria. 2Department of Biochemistry, School of Basic Medical Sciences, College of Pure and Applied Science,Kwara State University, Malete, P. M. B. 1530, Ilorin, Nigeria. 3Department of Chemistry, College of Sciences, University of Agriculture, P. M. B. 2373, Makurdi, Nigeria. Received 18 October, 2018; Accepted 4 November, 2018 Aristolochic acids are naturally occurring biomolecules found in plants of the genus Aristolochia and Asarum belonging to the family Aristolochiaceae. They are reported to be carcinogenic and nephrotoxic; and are implicated in kidney diseases, aristolochic acid nephropathy (AAN) which may result in kidney failure, other health complications and possibly death. Aristolochic acids are highly genotoxic and are linked to upper urothelial cancer in animals and humans. Some Aristolochia species are used in traditional medicine practice in Nigeria and other West African countries without regard to safety concerns. Several countries, especially in the Western world, have banned the use and importation of herbal products containing aristolochic acids.
    [Show full text]
  • Aristolochia Species and Aristolochic Acids
    B. ARISTOLOCHIA SPECIES AND ARISTOLOCHIC ACIDS 1. Exposure Data 1.1 Origin, type and botanical data Aristolochia species refers to several members of the genus (family Aristolochiaceae) (WHO, 1997) that are often found in traditional Chinese medicines, e.g., Aristolochia debilis, A. contorta, A. manshuriensis and A. fangchi, whose medicinal parts have distinct Chinese names. Details on these traditional drugs can be found in the Pharmacopoeia of the People’s Republic of China (Commission of the Ministry of Public Health, 2000), except where noted. This Pharmacopoeia includes the following Aristolochia species: Aristolochia species Part used Pin Yin Name Aristolochia fangchi Root Guang Fang Ji Aristolochia manshuriensis Stem Guan Mu Tong Aristolochia contorta Fruit Ma Dou Ling Aristolochia debilis Fruit Ma Dou Ling Aristolochia contorta Herb Tian Xian Teng Aristolochia debilis Herb Tian Xian Teng Aristolochia debilis Root Qing Mu Xiang In traditional Chinese medicine, Aristolochia species are also considered to be inter- changeable with other commonly used herbal ingredients and substitution of one plant species for another is established practice. Herbal ingredients are traded using their common Chinese Pin Yin name and this can lead to confusion. For example, the name ‘Fang Ji’ can be used to describe the roots of Aristolochia fangchi, Stephania tetrandra or Cocculus species (EMEA, 2000). Plant species supplied as ‘Fang Ji’ Pin Yin name Botanical name Part used Guang Fang Ji Aristolochia fangchi Root Han Fang Ji Stephania tetrandra Root Mu Fang Ji Cocculus trilobus Root Mu Fang Ji Cocculus orbiculatus Root –69– 70 IARC MONOGRAPHS VOLUME 82 Similarly, the name ‘Mu Tong’ is used to describe Aristolochia manshuriensis, and certain Clematis or Akebia species.
    [Show full text]
  • Analysis of the Analogues of Aristolochic Acid and Aristolactam in the Plant of Aristolochia Genus by HPLC
    40 Journal of Food and Drug Analysis, Vol. 12, No. 1, 2004, Pages 40-45 Analysis of the Analogues of Aristolochic Acid and Aristolactam in the Plant of Aristolochia Genus by HPLC JENQ-HUEI JOU1, CHIA-YING LI2, EDWARD P. SCHELONKA3, CHUN-HUA LIN2 AND TIAN-SHUNG WU2* 1. Department of Food Health, Chia Nan University of Pharmacy & Science, 60, Sec. 1, Erh-Jen Rd., Jen-Te Township, Tainan County 717, Taiwan (R.O.C.) 2. Department of Chemistry, National Cheng Kung University, 1 Ta-Hsueh Rd., East District, Tainan City 701, Taiwan (R.O.C.) 3. Good News Medical Clinic #14 Bally Garden, 4miles Northern Hy, Belize City, Belize Central America (Received: June 11, 2003; Accepted: September 26, 2003) ABSTRACT A facile reversed-phase HPLC method for the analysis of aristolochic acid (AA) and aristolactam (AL) analogues was developed and used for the quantitative determination and quality control of the traditional Chinese medicine. Homonymic Chinese crude drugs such as Stephania tetrandra ( ) and Aristolochia fanchi ( ), Clematis armandii ( ) and A. manshuriensis ( ) can be easily identified by this method. The quantitative determination of AAs and ALs in 12 species of Aristolochia (A. elegans, A. zollingeriana, A. cucurbitifolia, A. mollis, A. kaempferi, A. shimadii, A. heterophylla, A. debilis, A. foveolata, A. contorta, A. trilobata and A. odoratissima) has been investigated. The chromatograms obtained in this study can serve as fingerprints to identify plant species in the Aristolochia genus, thus avoiding incorrect identification of herbal ingredients in manufacturing traditional Chinese medicine. Key words: HPLC, aristolochic acid, aristolactam, Stephania tetrandra, Aristolochia fanchi, Clematis armandii, A.
    [Show full text]
  • Considérations Sur L'histoire Naturelle Des Ranunculales
    Considérations sur l’histoire naturelle des Ranunculales Laetitia Carrive To cite this version: Laetitia Carrive. Considérations sur l’histoire naturelle des Ranunculales. Botanique. Université Paris Saclay (COmUE), 2019. Français. NNT : 2019SACLS177. tel-02276988 HAL Id: tel-02276988 https://tel.archives-ouvertes.fr/tel-02276988 Submitted on 3 Sep 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Considérations sur l’histoire naturelle des Ranunculales 2019SACLS177 Thèse de doctorat de l'Université Paris-Saclay : préparée à l’Université Paris-Sud NNT École doctorale n°567 : Sciences du végétal, du gène à l'écosystème (SDV) Spécialité de doctorat : Biologie Thèse présentée et soutenue à Orsay, le 05 juillet 2019, par Laetitia Carrive Composition du Jury : Catherine Damerval Directrice de recherche, CNRS (– UMR 320 GQE) Présidente du jury Julien Bachelier Professeur, Freie Universität Berlin (– Institute of Biology) Rapporteur Thomas Haevermans Maître de conférences, MNHN (– UMR 7205 ISYEB) Rapporteur Jean-Yves Dubuisson Professeur, SU (–UMR 7205 ISYEB) Examinateur Sophie Nadot Professeure, U-PSud (– UMR 8079 ESE) Directrice de thèse « Le commencement sera d’admirer tout, même les choses les plus communes. Le milieu, d’écrire ce que l’on a bien vu et ce qui est d’utilité.
    [Show full text]
  • AHPA Guidance Policy
    AHPA Guidance Policy AHPA develops guidance policies to promote responsible commerce in herbal supplements. These policies address a variety of labeling and manufacturing issues and reflect the consensus of AHPA’s members and its board of trustees. AHPA encourages its members and non-member companies to adopt these policies to establish consistent and informed trade practices. Known Adulterants (adopted July 1997; revised July 2012) AHPA recommends that appropriate steps be taken to assure that the raw materials in the following table are free of the noted adulterant. This list identifies herbs and potential adulterants that are known at this time to have been encountered in trade. Additional information may be added if further such instances are observed. Marketers of products that contain herbal ingredients are responsible for assuring accurate identification of all ingredients. Contact AHPA for additional information regarding relevant analytical methods. Article of Trade Adulterant Eleuthero root (Eleutherococcus senticosus) Periploca sepium root Plantain leaf (Plantago lanceolata Digitalis lanata leaf Skullcap herb (Scutellaria lateriflora) Germander herb (Teucrium chamaedrys) Stephania root (Stephania tetrandra)a Aristolochia fangchi root (guang fang ji) Asian species of Cocculus, Diploclisia, Aristolochia fangchi root (guang fang ji) Menispermum and Sinomenium root Asian species of Akebia and Clematis stem Aristolochia manshuriensis stem (guan mu tong) Costus root (Saussurea costus)b Aristolochia debilis root (qing mu xiang) Vladimiria souliei root Aristolochia debilis root (qing mu xiang) Black cohosh root/rhizome (Actaea racemosa)c Chinese cimicifuga root/rhizomed (Actaea spp.) Ginkgo (Ginkgo biloba) leaf extract with added Ginkgo (Ginkgo biloba) leaf extract standardized flavonol glycosides or aglycones (e.g., rutin, to flavonol glycosides and terpenes quercetin, etc.) Bilberry fruit extract Red dye #2 (amaranth dye) Various powders, possibly including Opuntia Hoodia gordonii aerial parts powder spp.
    [Show full text]